Patents
Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
04/2008
04/02/2008EP1905771A2 Quinuclidine derivatives and their use
04/02/2008CN100378092C Biphenyl derivatives
04/02/2008CN100378074C 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
03/2008
03/27/2008US20080076927 safe and effective treatment of various gastrointestinal disorders including, but not limited to, gastroparesis, gastroesophageal reflux and related conditions. The compounds of the subject invention are also useful in treating a variety of conditions involving the central nervous sytem
03/26/2008CN100376569C Inhibitors of farnesyl protein transferase
03/25/2008US7348330 1-azabicyclo [2,2,2] octan-3-one derivatives
03/20/2008WO2008005910A3 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
03/20/2008US20080070906 Quinolinone derivatives
03/19/2008EP1900737A1 Polymorph of (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide
03/19/2008CN101146806A Pyrazole derivatives for the inhibition of CDK and GSK
03/18/2008US7345175 Biphenyl derivatives
03/13/2008WO2008012290A3 Quinuclidine derivatives as m3 antagonists
03/13/2008WO2007136570A3 5,6-fused pyrrolidine compounds useful as tachykinin receptor antagonists
03/13/2008US20080064726 Dipeptidyl peptidase-IV (DPP-IV) inhibitor; diabetes mellitus, insulin-resistant diseases, obesity, hypoglycemia ; 2-[4-({2-[(2S,4S)-2-cyano-4-fluoropyrrolidin-1-yl]-2-oxoethyl}amino)-4-methylpiperdin-1-yl]-2-oxoethyl acetate monofumarate
03/12/2008EP1896469A2 Fused bicycloheterocycle substituted quinuclidine derivatives
03/12/2008CN100374425C Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers
03/11/2008US7342028 Medical use for tachykinin antagonists
03/06/2008WO2008025541A1 Polymorph of (r) -3- (2-hydroxy-2, 2-diphenyl-acetoxy) -1- (isoxazol-s-ylcarbamoyl-methyl) -1-azoni a-bicyclo- [2.2.2] octane bromide
03/06/2008CA2660983A1 Polymorph of (r) -3- (2-hydroxy-2, 2-diphenyl-acetoxy) -1- (isoxazol-3-ylcarbamoyl-methyl) -1-azoni a-bicyclo- [2.2.2] octane bromide
03/05/2008CN101137654A Novel salt of quinuclidine derivative
02/2008
02/27/2008EP1891048A1 Pyrazole-substituted benzimidazole derivatives for use in the treatment of cancer and autoimmune disorders
02/27/2008EP1558610B1 Substituted aminoquinuclidine compounds and their use as delta-opioid receptor ligands
02/27/2008EP1268470B1 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof
02/26/2008US7335774 Quinolinone derivatives
02/26/2008US7335668 Gastrointestinal disorders; urogenital disorders
02/26/2008US7335656 Medical devices employing triazine compounds and compositions thereof
02/20/2008EP1889845A1 Novel pleuromutilin derivatives
02/20/2008EP1404704B9 Bridged bicyclic serine protease inhibitors
02/19/2008US7332610 Chemical intermediates for production of sibutramine
02/19/2008US7332507 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted
02/19/2008US7332490 inhibit smooth muscle cell proliferation by modulating Heparan Sulfate Proteoglycans (HSPGs); inhibit or block glycated protein and Advanced Glycation Endproducts (AGE) produced induction of the signaling-associated inflammatory response in endothelial cells; antiproliferative and antiinflammatory agent
02/19/2008US7332489 Methods and compositions of novel triazine compounds
02/19/2008US7332488 Methods and compositions of novel triazine compounds
02/14/2008US20080039516 Composition of Solifenacin or Salt Thereof for Use in Solid Formulation
02/14/2008US20080039493 Quinuclidine derivatives as M3 antagonists
02/14/2008CA2660349A1 2-aminobenzoxazole carboxamides as 5ht3 modulators
02/13/2008CN101124224A Nicotinic alpha-7 receptor ligands and preparation and uses thereof
02/06/2008EP1339712B1 3-substituted quinuclidines and their use as nicotinic agonists
02/06/2008CN101119994A Nicotinic acetycholine receptor ligands
02/05/2008US7326787 Preparing (R)-quinuclidin-3-yl 6-((3S,4R)-4-(4-amino-5-chloro-2-methoxybenzamido)-3-methoxypiperidin-1-yl)hexanoate; ethyl 4-amino-3-methoxypiperidine-1-carboxylate; benzylation; chiral salt; basification; ethyl 6-bromohexanoate; R)-quinuclidin-3-ol; deprotect; 4-amino-5-chloro-2-methoxybenzoic acid
01/2008
01/31/2008WO2008013269A1 Isoquinuclidine derivative and method for producing 1-cyclohexene-1-carboxylic acid derivative by using the same
01/31/2008WO2008012290A2 Quinuclidine derivatives as m3 antagonists
01/31/2008CA2658649A1 Quinuclidine derivatives as m3 antagonists
01/30/2008EP1882691A1 Quinuclidine derivatives as M3 antagonists
01/24/2008WO2008009397A1 Process for manufacturing 3(r)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide
01/24/2008US20080021060 Quinuclidine carbamate derivatives and their use as M3 antagonists
01/24/2008CA2657679A1 Process for manufacturing 3(r)-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide
01/23/2008EP1879887A2 Npy antagonists, preparation and use
01/23/2008EP1879867A2 Intermediates for preparing solifenacin
01/23/2008EP1532144B1 quinuclidine derivatives and their use
01/23/2008CN101108825A Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
01/23/2008CN100363363C Novel quinuclidine derivatives and medicinal compositions containing the same
01/17/2008WO2007075297A3 Muscarinic agonists and methods of use thereof
01/17/2008US20080015220 Biphenyl-2-ylcarbamic acid 1-{7-[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]heptyl}piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, chronic obstructive pulmonary disease and asthma
01/16/2008EP1877367A1 Acetylene derivatives
01/10/2008WO2008005910A2 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
01/10/2008US20080009624 Heteroaryl carboxamides
01/09/2008EP1874761A2 4h-1,2,4-triazin-5-one derivatives, their preparation and their use as alpha 7 nicotinic acetylcholine receptors
01/09/2008EP1711473B1 Substituted n-cyclohexylimidazolinones having an mch-modulatory effect
01/09/2008EP1601635B1 Process for producing optically active alcohol in the presence of rhodium, a chiral ferrocenyldiphosphine and an optically active diamine
01/08/2008US7317028 Antitumor agents; autoimmune disease; skin disorders; anticancer agents
01/08/2008CA2172513C Aminocyclohexylesters and uses thereof
01/02/2008EP1871772A1 Quinolinone compounds as 5-ht4 receptor agonists
01/01/2008US7314870 Compounds, their preparation and use
12/2007
12/27/2007WO2007149929A1 Piperidine derivatives for the treatment of gastrointestinal and cns disorders
12/27/2007WO2007147374A2 Process for the preparation of solifenacin
12/27/2007US20070299082 (+-)-3-(6-Phenylethynyl-pyridazin-3-yloxy)-1-aza-bicyclo[2.2.2]octane; (+-)-N-{4-[6-(1-Aza-bicyclo[2.2.2]oct-3-yloxy)-pyridazin-3-ylethynyl]-phenyl}-acetamide; nicotinic and monoamine receptor modulators
12/27/2007US20070299039 Substituted benz-azoles and methods of their use as inhibitors of Raf kinase
12/26/2007CN100357276C Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors
12/25/2007US7312335 Asymmetric Michael and Aldol additions using bifunctional cinchona-alkaloid-based catalysts
12/25/2007US7312231 Quaternization of compound for treatment of urogenital disorders, respiratory system disorders or gastrointestinal disorders
12/25/2007US7312208 Quaternary ammonium compounds
12/21/2007WO2007063418A3 Substituted indole compounds having nos inhibitory activity
12/20/2007US20070293498 used for the treatment of cachexia and other weight loss disorders, such as those resulting from cancer, HIV, old age and anorexia nervosa
12/19/2007EP1867654A1 Process for production of optically active quinuclidinol
12/19/2007EP1594869B1 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
12/19/2007CN101088999A Process of synthesizing 3-amino quinine dihydrochloride
12/19/2007CN100355419C Therapeutic agent for overactive bladder
12/18/2007US7309699 Such as 4'-(1-azabicyclo[2.2.2]oct-3-yloxy)-1,1'-biphenyl-3-amine; nicotinic acetylcholine receptor modulators; for treatment of attention deficit disorder, Alzheimer*s disease, or AIDS
12/13/2007WO2007141504A1 Fused thiophene derivatives as kinase inhibitors
12/13/2007US20070287743 Adamantyl Pyrrolidin-2-One Derivatives as 11-Beta Hydroxtsteroid Dehydrogenase Inhibitors
12/13/2007US20070287728 Novel Naphthyl Substituted Azabicyclo Derivatives and Their Use as Monomine Neurotransmitter Re-Uptake Inhibitors
12/12/2007EP1713801B1 Process for preparation of 1-(2s,3s)-2-benzhydr yl-n-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine
11/2007
11/29/2007US20070276003 Biphenyl-2-ylcarbamic acid 1-{7-[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]heptyl}piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, chronic obstructive pulmonary disease and asthma
11/29/2007US20070275975 3-quinuclidinyl amino-substituted biaryl derivatives
11/28/2007CN101080385A Amine salts of (-)-2-((2-(4-hydroxyphenyl)ethyl)thio)-3-(4-(2-(4-((methylsulfonyl)oxy)phenoxy)ethyl)phenyl)propanoic acid
11/28/2007CN100351249C Quinolinone derivatives as tyrosine kinase inhibitors
11/22/2007WO2007076116A3 Intermediates for preparing solifenacin
11/22/2007WO2005046589A3 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
11/22/2007US20070270458 Nicotinic Acetylcholine Receptor Ligands
11/22/2007US20070270453 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
11/20/2007US7297682 liquid crystal diphosphate polymorph; antibacterial and antiprotozoal agents
11/14/2007EP1853600A1 Pyrazole derivatives for the inhibition of cdk's and gsk's
11/14/2007EP1853597A1 Benzoxazole carboxamides for treating cinv and ibs-d
11/06/2007US7291731 7-(3-Pyridyl)-1,7-diazaspiro-[4,4]nonane and its salts and proline amides; capable of affecting nicotinic cholinergic receptors, e.g., as modulators of specific nicotinic receptor subtypes; neuroprotective agents
10/2007
10/31/2007EP1849782A1 Quinolinone derivatives as tyrosine kinase inhibitors
10/31/2007CN100345847C Novel biarylcarboxamides
10/30/2007US7288656 Derivatives of N-heterocyclylmethylbenzamides, preparation method thereof and application of same in therapeutics
10/25/2007WO2007119463A1 2-(cyclic amino)-pyrimidone derivatives as tpk1 inhibitors
10/25/2007US20070249664 Muscle relaxants; respiratory system disorders; asthma;COPD; emphysema; bronchitis
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 58